Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

New PKC inhibitors in development at AstraZeneca

Oct. 14, 1999

Preclinical, early clinical results indicate good efficacy and safety of D-4418

Oct. 13, 1999

Glaxo Wellcome receives approval in Germany for Flixotide in COPD

Oct. 13, 1999

News from ERS: tiotropium prevents methacholine-induced bronchoconstriction in asthmatics

Oct. 13, 1999

PDE3 inhibitor olprinone is an effective bronchodilator in asthma patients

Oct. 13, 1999

DHA: a new treatment for CF on the horizon?

Oct. 13, 1999

Positive phase I/II reported for Nuvance at European meeting

Oct. 13, 1999

Sheffield and Elan establish licensing agreement to develop respiratory products

Oct. 12, 1999

Sch-55700 prevents a variety of eosinophilic responses in animal models

Oct. 7, 1999

PKC, cytokine inhibitors in development at AstraZeneca

Oct. 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
XPC-837 restores network dysfunction in Dravet syndrome models
BioWorld Science
Researchers from Xenon Pharmaceuticals Inc. described the preclinical efficacy of XPC-837 in models of Dravet syndrome, a severe developmental and epileptic...